Today: 400 Shares of Chemed Corp. (CHE) Stock are sold by Patrick P. Grace

Today: 400 Shares of Chemed Corp. (CHE) Stock are sold by Patrick P. Grace

Chemed Corp. (NYSE:CHE) Director Patrick P. Grace sold 400 shares of Chemed Corp. stock in a transaction on Monday, November 28th. The stock was sold at an average price of $148.53, for a total transaction of $59,412.00. Following the transaction, the director now directly owns 4,597 shares in the company, valued at $682,792.41. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Chemed Corp. (NYSE:CHE) traded up 0.63% during midday trading on Monday, reaching $148.60. 202,316 shares of the company’s stock traded hands. Chemed Corp. has a 52-week low of $124.77 and a 52-week high of $159.76. The company has a 50 day moving average of $141.66 and a 200 day moving average of $137.72. The firm has a market cap of $2.41 billion, a PE ratio of 23.72 and a beta of 1.25.

Chemed Corp. (NYSE:CHE) last announced its quarterly earnings results on Wednesday, October 26th. The company reported $1.73 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.82 by $0.09. Chemed Corp. had a net margin of 6.77% and a return on equity of 23.95%. The business earned $392.61 million during the quarter, compared to analyst estimates of $270.44 million. During the same quarter last year, the company posted $1.78 earnings per share. The company’s revenue was up 1.7% compared to the same quarter last year. On average, equities analysts predict that Chemed Corp. will post $7.24 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 5th. Stockholders of record on Monday, November 14th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.70%. The ex-dividend date of this dividend is Wednesday, November 9th. Chemed Corp.’s dividend payout ratio (DPR) is presently 16.59%.

Several large investors have recently bought and sold shares of CHE. Nordea Investment Management AB boosted its stake in Chemed Corp. by 292.7% in the second quarter. Nordea Investment Management AB now owns 4,810 shares of the company’s stock valued at $656,000 after buying an additional 3,585 shares during the period. Capital Fund Management S.A. boosted its stake in Chemed Corp. by 8.6% in the second quarter. Capital Fund Management S.A. now owns 31,008 shares of the company’s stock valued at $4,227,000 after buying an additional 2,455 shares during the period. Smith Asset Management Group LP boosted its stake in Chemed Corp. by 3.6% in the second quarter. Smith Asset Management Group LP now owns 23,229 shares of the company’s stock valued at $3,166,000 after buying an additional 800 shares during the period. Bank of Montreal Can purchased a new stake in Chemed Corp. during the second quarter valued at $499,000. Finally, Parametrica Management Ltd purchased a new stake in Chemed Corp. during the second quarter valued at $369,000. Institutional investors own 97.40% of the company’s stock.

A number of equities analysts have recently weighed in on CHE shares. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $155.00 price target on shares of Chemed Corp. in a research report on Tuesday, September 27th. Zacks Investment Research cut shares of Chemed Corp. from a “hold” rating to a “sell” rating in a research report on Tuesday, November 1st. RBC Capital Markets reaffirmed a “sector perform” rating and issued a $148.00 price objective (down from $162.00) on shares of Chemed Corp. in a research report on Tuesday, November 1st. Royal Bank Of Canada cut their price objective on shares of Chemed Corp. from $162.00 to $148.00 and set a “sector perform” rating on the stock in a research report on Tuesday, November 1st. Finally, JMP Securities reaffirmed a “hold” rating on shares of Chemed Corp. in a research report on Sunday, September 4th. Four investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus target price of $154.50.

Chemed Corp. Company Profile

Related posts

Leave a Comment